Entity Common Stock, Shares Outstanding of AGILE THERAPEUTICS INC from 13 Aug 2014 to 12 Aug 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
AGILE THERAPEUTICS INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 13 Aug 2014 to 12 Aug 2024.
  • AGILE THERAPEUTICS INC Entity Common Stock, Shares Outstanding for the quarter ending 12 Aug 2024 was 6,904,498, a 258% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

AGILE THERAPEUTICS INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 6,904,498 +4,977,988 +258% 12 Aug 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 6,856,229 -39,682,021 -85% 27 Mar 2024 10-K 28 Mar 2024 2023 FY
Q3 2023 2,511,657 -38,102,870 -94% 07 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,926,510 -37,096,513 -95% 07 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 46,538,250 -88,078,612 -65% 14 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 40,614,527 -80,781,506 -67% 04 Nov 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 39,023,023 -53,976,941 -58% 10 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 134,616,862 +46,353,121 +53% 25 Mar 2022 10-K 30 Mar 2022 2021 FY
Q3 2021 121,396,033 +33,961,429 +39% 29 Oct 2021 10-Q/A 30 Dec 2021 2021 Q3
Q2 2021 92,999,964 +5,702,359 +6.5% 23 Jul 2021 10-Q 26 Jul 2021 2021 Q2
Q1 2021 88,263,741 +1,050,529 +1.2% 30 Apr 2021 10-Q 04 May 2021 2021 Q1
Q3 2020 87,434,604 +28,132,478 +47% 09 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 87,297,605 +42,521,794 +95% 07 Aug 2020 10-Q 11 Aug 2020 2020 Q2
Q1 2020 87,213,212 +43,998,829 +102% 01 May 2020 10-Q 05 May 2020 2020 Q1
Q3 2019 59,302,126 +24,924,797 +73% 28 Oct 2019 10-Q 28 Oct 2019 2019 Q3
Q2 2019 44,775,811 +10,398,482 +30% 31 Jul 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 43,214,383 +8,966,115 +26% 11 Mar 2019 10-K 12 Mar 2019 2018 FY
Q3 2018 34,377,329 +190,987 +0.56% 01 Nov 2018 10-Q 02 Nov 2018 2018 Q3
Q2 2018 34,377,329 +5,570,931 +19% 02 Aug 2018 10-Q 03 Aug 2018 2018 Q2
Q1 2018 34,248,268 +5,471,870 +19% 09 Mar 2018 10-K 12 Mar 2018 2017 FY
Q3 2017 34,186,342 +5,428,623 +19% 03 Nov 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 28,806,398 +53,679 +0.19% 27 Jul 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 28,776,398 +38,848 +0.14% 10 Mar 2017 10-K 15 Mar 2017 2016 FY
Q3 2016 28,757,719 +6,465,552 +29% 04 Nov 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 28,752,719 +6,481,118 +29% 05 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 28,737,550 +6,583,185 +30% 04 Mar 2016 10-K 09 Mar 2016 2015 FY
Q3 2015 22,292,167 +3,699,199 +20% 09 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 22,271,601 +3,678,633 +20% 12 Aug 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 22,154,365 16 Mar 2015 10-K 26 Mar 2015 2014 FY
Q3 2014 18,592,968 13 Nov 2014 10-Q 13 Nov 2014 2014 Q3
Q2 2014 18,592,968 13 Aug 2014 10-Q 14 Aug 2014 2014 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.